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Abstract 
 
A comprehensive Collision Cross Section (CCS) library was obtained via travelling wave ion 
guide mobility measurements through direct infusion (DI). The library consists of CCS and 
Mass Spectral (MS) data in negative and positive ElectroSpray Ionisation (ESI) mode for 463 
and 479 endogenous metabolites, respectively. For both ionisation modes combined, TWCCSN2 
data were obtained for 542 non-redundant metabolites. These data were acquired on two 
different ion mobility orthogonal acceleration QToF MS systems in two different laboratories, 
with the majority of the resulting TWCCSN2 values (from detected compounds) found to be 
within 1% of one another. Validation of these results against two independent, external 
TWCCSN2 data sources and predicted CCS values indicated be within 1-2% of these other 
values. The same metabolites were then analysed using a rapid reversed-phase ultra (high) 
performance liquid chromatographic (U(H)PLC) separation combined with IM and MS (IM-
MS) thus providing retention time (tr), m/z and 
TWCCSN2 values (with the latter compared with 
the DI-IM-MS data). Analytes for which TWCCSN2 values were obtained by U(H)PLC-IM-MS 
showed good agreement with the results obtained from DI-IM-MS. The repeatability of the 
TWCCSN2 values obtained for these metabolites on the different ion mobility QToF systems, 
using either DI or LC, encouraged the further evaluation of the U(H)PLC-IM-MS approach via 
the analysis of samples of rat urine, from control and methotrexate-treated animals, in order to 
assess the potential of the approach for metabolite identification and profiling in metabolic 
phenotyping studies. Based on the database derived from the standards 63 metabolites were 
identified in rat urine, using positive ESI, based on the combination of tr, 
TWCCSN2 and MS 
data. 
 
Keywords: Ion mobility spectrometry, collision cross section, metabolic phenotyping, 
metabonomics, metabolomics. 
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1. Introduction 
 
There is increasing interest in the application of ion mobility spectrometry (IMS) in metabolic 
phenotyping (metabolomics/metabonomics) [1-3] and lipidomic studies [4-12] where it is 
widely recognized that both the separation and identification of the many hundreds/thousands 
of metabolites present in samples can represent a major problem for the investigator seeking to 
find mechanistic “biomarkers”. For the detection and identification of analytes present in 
complex mixtures, such as biological fluids, both the additional separation afforded by IM and 
the collision cross section (CCS) areas obtained can potentially be of great benefit. Thus, the 
extra orthogonal separation that can be added by IMS to both DI and chromatographic analysis 
can enable the resolution of co-eluting species via differences in analyte mobility rather than 
e.g., differences in LogP as used in e.g., reversed-phase LC separations. This separation not 
only increases the number of “features” (mass/retention time pairs) detected using MS, but also 
can provide better MS data by reducing spectral overlap. The orthogonality between separation 
methods has been discussed previously by e.g., Frahm et al [13] and Rodriguez-Suarez et al. 
[14]. Thus the available m/z space that can be occupied by a mass analyser, and the 
consequences of this are on total system peak capacity when one and two-dimensional 
separation methods are included in the analysis, are discussed conceptually in [13]. Rodriguez-
Suarez et al. [14] determined empirically that the number of precursor and product ions 
detected increased on average by a factor of 1.3 when IM was added to either a 1DLC-IM-MS 
or 2DLC-IM-MS schema. A similar increase in the number of deconvoluted features was noted 
by Rainville et al. [15] when comparing the addition of ion mobility to reversed-phase 
separations of metabolites in urine using different gradient and column lengths. Moreover, as 
the CCS value is a physicochemical measurement, it can greatly aid identification, or 
confirmation of identity. As a result, LC-based applications that include IMS for 
metabolomics/metabonomics area have begun to grow in number [15-18] and there is also 
interest in employing IMS in capillary electrophoresis [19]. Previously we have shown that an 
increased number of features can be detected using U(H)PLC-IM-MS compared to U(H)PLC-
MS alone, with various combinations of column length and gradient time [15]. Here, as part of 
ongoing studies looking to the application of IMS in metabolic phenotyping, TWCCSN2 
measurements have been measured in triplicate for a library of some 614 metabolites, on each 
of two different ion mobility-enabled mass spectrometers located in different laboratories. The 
test metabolites (IROA Mass Spectrometry Metabolite Library of Standards) were first 
analysed individually using DI on the two ion mobility-enabled mass spectrometers (DI-IM-
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MS) and the results additionally validated using external resources. The same set of compounds 
was then analysed, in duplicate, by microcolumn reversed phase U(H)PLC-IM-MS, using a 
previously described rapid gradient (“RAMMP LC”) method [20], to obtain retention time (tr) 
data to further aid metabolite identification in a test set of rat urine samples [21] run under the 
same conditions. 
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2 Materials and Methods 
 
2.1 Chemicals and reagents 
 
Solvents were of LC-MS grade with water containing 0.1% formic acid (v/v), or LC-MS grade 
water, both purchased from Fisher Scientific (Loughborough, UK); LC-MS grade acetonitrile 
containing 0.1% formic acid (v/v) and LC-MS grade methanol and LC-MS grade ethanol were 
purchased from Sigma Aldrich (Gillingham, Dorset, UK), whilst formic acid was purchased 
from Fisher Scientific (Loughborough, UK). The test metabolites (the Mass Spectrometry 
Metabolite Library of Standards (MSMLS), in 96 well plates, (5 µg sample per well) were 
obtained from IROA Technologies, (Bolton, MA). Samples in plates one to four were dissolved 
in 400 µL water, those in plate five were dissolved in 400 µL 40% methanol in water (v/v), 
whilst for plate six, some standards were dissolved in 400 µL 40% methanol in water and some 
in 400 µL water, and for plate seven the standards were dissolved in 400 µL of a 1:1 v/v 
water:ethanol mixture. The resulting analyte concentrations were 12.5 µg/mL for each 
compound. For a full compound listing, plate positioning, molecular formula and molecular 
mass see Table S1 in the supplementary data.  
 
For the calibration of the IMS a mixture of compounds was used, covering a range of m/z values 
and selected for use in either positive of negative ESI modes. These calibrants, and their 
sources, are listed in Table 1 below, along with their source. The Major Mix IMS/ToF 
Calibration Kit was obtained from Waters Corporation, Wilmslow, UK. Compounds with the 
source Sigma Aldrich were purchased from Sigma-Aldrich, Gillingham, Dorset, UK. 
Compounds marked with Alfa Aesar were purchased from Alfa Aesar, Heysham, Lancashire, 
UK. 
 
For mass calibration, a 0.5 M sodium formate solution in water:isopropanol 1:1 v/v was 
used(Alfa Aesar) . This solution was infused directly into the mass spectrometer, creating a 
range of sodium formate clusters (when measuring between m/z 50 - 1200), with m/z values 
ranging from 91.0 to 1178.8 in positive-ion mode, and from 113.0 to 1132.8 in negative-ion 
mode, which were compared to reference values to calibrate the time-of- flight tube analyser 
of the mass spectrometers.  
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2.2 Direct infusion (DI) two site determination of TWCCSN2 values 
 
Two sites and two different mass spectrometers were used to determine TWCCSN2 values via 
DI-IM-MS using an HDMS acquisition method. The sites and equipment involved in this study 
were: 
 
1. A Synapt G2-S Ion Mobility QToF mass spectrometer (Wilmslow, UK) located in the 
Section of Computational and Systems Medicine within the Department of Surgery and 
Cancer at Imperial College, London, UK. 
2. A Synapt G2-Si Ion Mobility QToF mass spectrometer located at Waters Corporation, 
Wilmslow, Cheshire, UK. 
 
The two Synapt G2-S and G2-Si platforms hold the same travelling wave ion guide 
configuration, but the ionization source and ion transfer optics of the G2-Si version of the 
instrument were changed to improve overall ion transmission through the IM-MS instrument. 
Prior to use the ion mobility cell settings were standardised for both systems by setting the 
following values for each instrument: 2 mL/min gas flow for the Trap cell, 90 mL/min gas flow 
for the mobility (IMS) cell and 180 mL/min for the helium cell, with ramping the mobility cell 
velocity from 1100 m/s to 300 m/s with a constant wave height of 40 V. 
 
The pressure in the helium cell was approximately 91 bar and the pressure in the IMS cell 0.23 
bar. Calibration of the drift cell was achieved using the same combination of compounds, as 
detailed in the materials and methods section (Table 1), and reference values for both 
instruments. The calibration details are provided in the following paragraph. The instruments 
were then finally mass calibrated with sodium formate prior to use. LockSpray data were 
recorded for single point calibration during acquisition. 
 
The mass spectrometers were operated in positive or negative ESI modes with the resolving 
quadrupole set to a wide pass mode, with a low energy function in continuum mode acquired 
at a scan rate of 500 ms with an interscan time of 15 ms over the m/z range 50 to 1200. The 
instrument was operated in electrospray mode with LockSpray enabled. The capillary voltage 
was set to 3 kV in positive-ion mode and 0.5 kV in negative-ion mode; the following conditions 
were the same for both ion modes: cone voltage 30 V, source temperature 120 ºC. For positive-
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ion mode, desolvation gas temperature was 300 ºC with a flow rate of 600 L/hr, and in negative-
ion mode the desolvation gas temperature was 450 ºC with a flow rate of 1000 L/hr. Leucine 
enkephalin was employed as the LockSpray solution at a concentration of 200 pg/µL acquired 
every quarter of a minute with 3 scans averaging to provide a single point mass and TWCCSN2 
calibration. 
 
2.2.1 Travelling-Wave Ion Mobility CCS (TWCCSN2) Calibration Procedure 
 
The Travelling-Wave ion mobility CCS calibration procedure has been described in detail 
previously [22-24]. The methodology adopted for metabolite CCS measurement was 
calibration of T-Wave mobility with ionic species of known CCS (Ω) using standard drift tube 
instruments, whilst the IM-MS definitions employed were taken from Gaelica et al [25].  The 
T-Wave ion mobility drift times were calibrated using singly charged ions formed from Major 
Mix IMS/Tof compounds complemented with polyalanine, UltraMark 1621 and several 
organic acids (Table 1). Protonated and deprotonated species of these molecular species 
provided a mobility calibration over the CCS range from 130-306 Å2 (m/z 151-1921) and from 
117-367 Å2 (m/z 118-1967) for positive and negative ESI, respectively. The normalized 
collision cross section (Ω') values [(Ω' = (Ωpublished x (√µ/z), where µ = reduced mass and z = 
charge, were fitted against corrected drift time (t'd) values of the calibrant ions using power 
regression. The derived calibration coefficients were used to calculate the TWCCSN2 of the 
individual metabolites following measurement of their individual drift times (t'd) by the 
analysis software. 
 
2.2.2 DI-IM-MS 
 
Loop injections (5 µL in positive-ion mode and 10 µL in negative-ion mode) of each of the 
individual standards from the IROA MSMLS metabolites were made in triplicate (on the same 
day) using an AQUITY UPLC I-Class sample manager (Waters Corporation, Milford, MA) at 
each site, in both positive and negative electrospray (ESI) ion-mode, resulting in up to 12 
measurements per analyte. Samples were infused for 60 s via the LC system, with the LC 
column replaced with 100 cm of 0.004 inch i.d. PEEK tubing to ensure that the sample 
produced a signal for approximately 40 s, using a solvent of water:acetonitrile (1:1 v/v), 
containing 0.1% formic acid, at a flow rate of 0.05 mL/min. Each sample was injected 
individually to ensure no suppression of signal. Detection was considered when a compound 
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was measured in at least two technical replicates and confirmed when detected at one and 
measured at the other site. 
 
2.2.3 U(H)PLC-IM-MS 
 
This part of the study was performed on the Synapt G2-S Ion Mobility QToF instrument at 
Imperial College with the chromatographic separation performed using an AQUITY UPLC I-
Class system. The U(H)PLC conditions were those previously described [24] as the “RAMMP” 
method and employed a short reversed-phase gradient (2.5 min including re-equilibration) 
using a 1 x 50 mm HSS T3 1.8 µm column to provide a high throughput chromatographic 
separation. For the U(H)PLC-IM-MS experiments, the MSMLS test metabolites were each 
injected individually (5 µL), in duplicate, at the same concentration as for the DI-IM-MS 
experiments (12.5 µg/mL) in order to obtain retention time, TWCCSN2 and MS data. Duplicates 
for positive and negative-ion mode data were acquired. 
 
2.2.4 Application of U(H)PLC-IM-MS to Rat Urine Samples 
 
A set of ten rat urine samples, obtained from 5 vehicle dosed control and 5 treated animals 
following a single oral dose (40 mg/kg) of methotrexate (MTX), were used to evaluate the IMS 
system. These samples, taken 48-hours after the commencement of the study, represent a subset 
of those obtained during an investigation by the University of Arizona in collaboration with 
Imperial College London (ICL) on the effects of MTX on healthy animals and in NASH (non-
alcoholic steatohepatitis) models to explore the association between liver pathology and 
adverse drug reactions (ADRs) induced by MTX treatment [21]. The study approved by the 
Institutional Animal Care and Use Committee (IACUC) at the University of Arizona. The work 
was undertaken in with the NIH guidelines on the care and use of experimental animals as 
previously described [21]. 
 
The rat urine samples were prepared as described previously [24]. Briefly, 20 µL of each urine 
sample was mixed with 60 µL of MeOH and stored at -20˚C overnight for protein removal. 
The samples were then centrifuged (15,000 g, 5 min, 4˚C). From the supernatants, 25 µL was 
transferred into a 350 µL 96 well-plate and 225 µL of water was then added to each sample. 
The plates were centrifuged (700 g, 5 min) and placed into the auto sampler at 4 ˚C. The 
samples were analysed in positive ESI-ion mode using a sample volume of 5 μL under the 
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same conditions as those used to acquire the data for the standards apart from the MS scan rate, 
which was set at 100 ms and the desolvation gas temperature, which was set at 450 ºC. 
 
2.2.5 Machine Learning Procedure 
 
TWCCSN2 predictions were obtained with a model trained with machine learning. The approach 
is similar to the method of Zhou et al. [26] but is trained with TWCCSN2 to fit an appropriate 
model. The WCCSN2 data that were internally acquired with IMS-Q-oaToF and Q-IMS-oaToF 
geometries and covers a wide range of polarity and a large number of chemical classes. For 
each compound, 196 chemical descriptors were extracted [27,28] and a model was trained with 
a gradient boosting algorithm [29]. TWCCSN2 predictions for compounds described here were 
obtained using a nested 10-fold cross-validation strategy [27,30]. This means that the 
compounds and their TWCCSN2 predictions were not part of the training set used for optimizing 
the model parameters and hyperparameters. Prediction method and model details are presented 
elsewhere [30]. 
 
2.2.6 Data Analysis 
 
The DI-IM-MS acquired data were processed, including 4D peak detection, lock mass and drift 
lock correction, and targeted screening, using UNIFI Scientific Information System software 
1.8.2.0 (Waters Corporation, Milford, MA). The LC-IM-MS data were processed with UNIFI 
and Progenesis QI (Nonlinear Dynamics, Newcastle upon Tyne, UK). In positive-ion mode, 
the protonated, sodiated and potassiated adducts were searched for, and in negative-ion mode, 
only deprotonated adducts, using a 5 ppm mass tolerance. Multivariate analysis was conducted 
with SIMCA-P+ v11 (Umetrics, Malmö, Sweden). Chemical classification of the content of 
the MSMLS library was conducted with ClassyFire [32] and the Medical Subject Headings 
(MeSH) controlled vocabulary (https://pubchem.ncbi.nlm.nih.gov/classification) applied for 
application centric classification of the compounds. 
 
  
 10 
 
3. Results and Discussion 
 
3.1 Direct infusion IM-MS Studies 
 
As indicated in the introduction, the application of IMS in e.g., LC-MS-based metabolic 
phenotyping studies offers both an orthogonal, and rapid, separation in addition to that provided 
by chromatography or electrophoresis. IMS also provides a degree of separation in DI-MS-
based assays. For both DI-MS and LC-MS-based analyses IMS can, in addition, also be used 
to acquire ion-specific physicochemical measurements under a set of given experimental 
conditions in the form of the CCS values. Whilst MS-dependent data, such as e.g. the molecular 
mass of a compound can be determined with high accuracy using ion mobility enabled MS 
acquisitions, and is readily transferable between instruments and laboratories, it is less clear 
that CCS measurements are as robust. We therefore undertook a two site investigation using 
two similar, but not identical, IMS-capable MS instruments to determine both the within and 
between site repeatability of CCS determinations. At this stage of the analysis, the 
identification of a compound was accepted when it was detected at both sites using the criteria 
specified in the Experimental Section. In total, in positive-ESI mode, IM-MS data for 510 
compound measurements were initially obtained and TWCCSN2 values and mass spectra 
recorded. Following careful review of the data and the removal of adducts and the duplicates 
within the MSMLS set, TWCCSN2 values and mass spectra for a total of 463 unique compounds 
were obtained by combining the data from both sites. However, differences were noted between 
sites in terms of unique compounds detected by MS. Consequently, 404 of the MSMLS 
standards were detected at site 1, whilst another 404 were detected at site 2, with some 
compounds (118) only detected on one IMS-MS system or the other instruments, but not both. 
As a result, the detection and TWCCSN2 values of only 345 compounds were common to both 
instruments. Such differences are not unexpected given that differences in ionisation efficiency 
between different instruments are frequently observed.  The formed adducts were broadly the 
same for both instruments; however, for a subset of 36 compounds, different adducts (H+, Na+, 
or K+) were detected. For those compounds observed in positive ESI by both sites, with the 
same adduct, a maximum relative TWCCSN2 difference of 2% was found between the averaged 
TWCCSN2 values from the two sites. The detected 
TWCCSN2 values for DI-IM-MS using +ve 
ESI MS are summarised in supplementary Tables S2a. 
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Similarly, in negative ESI mode, IM-MS results were obtained for a total of 479 unique 
compounds. Once again, not all compounds were detected using both instruments, with 418 for 
site 1 and 437 detected by site 2. Overall, 376 compounds were detected by both instruments 
at both sites, with a further 103 compounds only detected by one site or the other. In negative 
ESI mode, all compounds measured by both sites were well within 2% of the averaged 
TWCCSN2 values. The detected 
TWCCSN2 values for DI-IM-MS with negative ESI MS are given 
in supplementary Table S2b). The measurement error distributions, i.e. the % differences 
between the average TWCCSN2 values from the two sites for both positive and negative ESI, 
following curation as described in the following two sections and centring as expected at means 
of 0%, are shown in Figure 1. 
 
The 79 compounds in the MSMLS test set that were detected in neither positive nor negative 
ESI mode are listed in the supplementary Table S3. The majority of these non-detected 
metabolites (47) had a neutral molecular mass of below m/z 150 and, whilst such compounds 
may be often detectable, the TWCCSN2 accuracy obtained could be lower. Improved detection 
below m/z 150 can be achieved by optimization of the gas pressure and ion optics voltage in 
certain regions of the instrument. This was however not considered since CCS would add little 
additional specificity to the detection of such low molecular mass compounds. Moreover, these 
would not represent typical high-throughput metabolomics settings, i.e. experimental MS 
conditions. A small number of the non-detected metabolites had a relatively high molecular 
mass, with 5 compounds having a molecular mass greater than 600 Da, the largest being 
vitamin B12 at 1354.6 Da. 
 
The results of the DI-IM-MS experiments, following further curation and statistical outlier 
removal, either the inter or intra sample standard deviation, or both, exceeding a 95% 
confidence level, are graphically summarised in Figures 1 to 4. The TWCCSN2 and MS/MS 
coverage and intersection for both ionisation modes are shown in Figure 2. Site two also 
collected accurate mass CID MS/MS data [33] that can additionally be used in the identification 
schema as demonstrated in supplementary Figure S1. Since, as previously mentioned, some 
MSMLS compounds are represented more than once, in different (adducted) forms or as 
duplicates, within the library, experimental TWCCSN2 data were obtained for a total of 568 
species/compound forms. The results shown in Figure 1 demonstrate both inter and intra site 
precision and provide a comparison with external data available in the public domain [34]. 
Note that the latter IMS data were acquired using a previous generation travelling wave enabled 
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IM-MS instrument (Synapt HDMS Q-TOF Mass Spectrometer, Waters Corporation) and used 
a different informatics analysis tool, comprising another peak detection algorithm, for data 
processing. Therefore, slightly higher deviations are to be expected but the reported values 
were still found to be within the expected error distribution range. However, the intra-site 
precision results illustrate the robustness/repeatability of IMS measurements of modern IM-
MS instruments since the data was, in part, i.e. the Paglia et al. data set [34] vs. site 1, 2 (and 
3) results, acquired more than five years apart. A recent study demonstrated similar inter and 
intra-day precision figures of merit using a different IMS analyser type [35, 36]. Both external 
data sets are provided as a reference in supplementary Table S4. A comparison of the obtained 
vs. predicted TWCCSN2 values, including an assessment of the accuracy of predictions using 
publically available CCS data [26] and instrument specific training data sets, is provided in 
Figure 3. The prediction errors for most analytes are within 2 %, and thus show that the 
predicted TWCCSN2 values are highly correlated with the experimentally observed values. 
Lastly, the detected vs. non-detected MSMLS library compound distributions and the relative 
class specific detected vs. non-detected class specific ratio for both ionisation modes are shown 
in in Figure 4, illustrating that three chemical classes in particular were underrepresented in 
negative electrospray mode compared to positive electrospray ionization, namely 
organometallic, represented by a mere two compounds with the MSMSL library as a whole, 
organic nitrogen compounds, represented by 22 compounds, and benzenoids, represented by 
50 compounds. The curated and comparative results are summarised numerically in Table 2. 
 
As can be observed from Figures 1 to 4 and supplementary Tables 2a and 2b, the TWCCSN2 
values from the different sites show slight, but very minor biases. In addition, some compounds 
were detected in the protonated form at one site, and as sodiated adducts at the other, or vice 
versa, possibly caused by differences in glassware and/or solvents used. As adduct formation 
is an in-source phenomenon, and instrument and experimental settings dependent, and as the 
TWCCSN2 values differed slightly, despite having, as far as possible, identical settings, and being 
calibrated in the same way, it may be that, at least in the short term, databases involving CCS 
information would need to be tailored for individual instruments and/or geometries. Lastly, as 
illustrated in Figure 5, it was noted that the observed TWCCSN2 data correlated well with class-
specific m/z values, which has been previously reported for lipids and other compound classes 
[6,11,12, 37].  
 13 
 
3.2 Comparison of DI-IM-MS vs. U(H)PLC-IM-MS  
 
The addition of a chromatographic LC separation step prior to IM-MS resulted in a reduction 
in the number of detected metabolites. This reduction in detectability was probably due, at least 
in part, to compounds either not being retained, or not eluted, from the column, and eluting 
within the solvent front. Poor chromatographic properties and ion suppression may also have 
been contributing factors. Nevertheless, a total of 301 compounds were detected with the rapid 
U(H)PLC-IM-MS method in positive-ion mode providing a complete set of TWCCSN2 values, 
MS and tr data for these metabolites (the complete list is provided in supplementary Table S5). 
Comparison of the LC-derived TWCCSN2 values against the averaged values found from direct 
infusion showed that 270 (89.7%) of the LC-IM-MS-detected compounds were within ±1% 
and 292 (97.0%) were within ±2% of the values obtained from DI-IM-MS. The remaining nine 
compounds showed somewhat larger differences for the TWCCSN2 values, possibly because of 
low abundance/challenged ion statistics, with the sodiated adduct of gamma-linolenic acid 
showing the largest deviation at 4.7%. A comparison of the obtained average values for DI-
MS and LC-MS/MS is provided in Figure 6. 
 
3.3 Identification of metabolites in rat urine by RP-RAMMP-U(H)PLC-IM-MS/MS 
 
The identification of metabolites in biological samples such as urine provides a particular 
problem for metabolomic/metabonomic studies because of the complexity of the mixtures of 
metabolites encountered and their structural diversity.  In Figure 7 the type of data that can be 
obtained for a sample of rat urine using the combination to U(H)PLC-IM-MS is shown.  
The MSMLS sample set contains a wide range of metabolites, not all of which are likely to be 
present in samples such as urine (e.g., NAD, fructose 1,6-biphosphate, 2'-deoxyguanosine  
5'-triphosphate, etc.), even if such compounds were retained under the reversed-phase LC 
conditions employed here. However, the data for the ten rat urine samples (five from control 
and five from methotrexate-dosed animals) analysed with the RAMMP method in positive ESI 
mode were searched against the database created from the TWCCSN2 values obtained from the 
direct infusion experiments of the whole MSMLS sample set. To be considered positive any 
putative database identification from this compound search had to meet the dual criteria of 
having a TWCCSN2 value within 2% of the mean DI-IM-MS value and an m/z within 10 ppm of 
that of the suggested metabolite. The resulting list of potential urinary-excreted metabolites 
indicated as being present by this search was then further assessed with respect to the RAMMP-
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derived tr, which had to be to be within 0.2 min of the library value, thereby providing three 
points of contact for each metabolite, and clearly indicating where further confirmation by 
reanalysis after spiking in an authentic standard would be appropriate.  
 
Of the nearly 300 compounds from the MSMLS sample set detectable in positive ESI using 
the RP-LC RAMMP-IM-MS method the putative identification of 63 metabolites (some of 
which were detected in only 1 sample) was supported by all three criteria with the TWCCSN2 
values reported in Tables S2a and S2b, and the retention time data provided in the 
supplementary information (Table S6). The repeatability of the retention time data obtained 
for these analytes is also indicated by the data provided in Table S6.  
Whilst this represents a relatively small proportion of the total number of ~ 2,700 deconvoluted 
compounds, i.e. the grouping of the features of multiple adduct forms and charge states into a 
single neutral mass, present in these samples it nevertheless represents a promising start and, 
as compound collections/databases increase in size, should help to reduce the bottleneck of 
compound identification for relatively common (and therefore commercially available) 
metabolites that currently plagues metabolic phenotyping studies. However, in our view (at 
least for the foreseeable future) MS and CCS values alone will still be insufficient for 
unequivocal identification and chromatographic retention time data will remain key to 
discriminating between isomeric compounds (and should there be no chromatographic 
separation in the LC system used one would have to be specifically developed). Such 
compounds represent a significant subset of important metabolite classes (e.g., 
monosaccharides) and unequivocal identification may still require comparison with an 
authentic standard on the same system. The results shown top right in Figure 6 graphically 
illustrate the precision of the TWCCSN2 measurements for urine, from both the control and the 
MTX-dosed animals, as a function of identification frequency. The average % CV values vs. 
the library complement were 0.5% and 0.6% for the control and MTX-dosed rat urine samples, 
respectively. Note that these relative values are derived from native urine metabolite ion 
detections and can therefore be of low abundance, thereby potentially challenging ion statistics 
and the subsequent m/z, TWCCSN2 and intensity read-outs. Shown bottom right in Figure 6 are 
the unsupervised PCA results of the tentatively identified metabolites, illustrating that 
differentiation of the samples was feasible based on a subset of identified compounds for m/z, 
tr, 
TWCCSN2, and abundance. 
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As is clear from the data provided in Table 3, there are several compounds detected in the 
samples from all, or the majority, of animals, such as e.g., 3-(2-hydroxyphenyl)propanoate, 
3',5'-cyclic AMP, 5-hydroxy-L-tryptophan, 5'-methylthioadenosine, adenine, adenosine, 
creatine, creatinine, D-pantothenic acid, lumichrome (6,7-dimethylalloxazine), riboflavin, 
sphinganine, suberic acid, sucrose, trans-cinnamate, urocanate, xanthine and xanthurenic acid 
whilst others were found less frequently, including some such as urate and taurine which were 
detected only in a single sample. 
 
Clearly, had this been a full-scale metabolic phenotyping exercise, with the aim of biomarker 
discovery, rather than a more limited “proof of concept” exercise, metabolite identification 
would have been concentrated on those compounds that discriminated between the control and 
MTX-treated groups. The use of rotationally averaged collisional cross sections as a means for 
identification and confirmation of compound identity is an intriguing prospect, providing a 
physicochemical supplement to retention time and tandem MS information. The limiting factor 
is currently the lack of CCS measurements populated into metabolite compound libraries, and 
the lack of computational tools to rapidly generate theoretical, either calculated using molecular 
modelling approaches [38] or predicted with machine learning based tools [26,39], CCS values 
from compound structure. Although there has been development, across multiple areas of 
research, in terms of empirical library development [40-43], including pesticides, veterinary 
drugs, mycotoxins, metabolism, steroids and steviol glycosides, undoubtedly further progress 
will make the routine use of IMS information for identification purposes a powerful analytical 
complement. On the basis of this investigation it is however clear that rapid U(H)PLC-IM-MS 
shows promise when applied to biological samples. 
 
4. Conclusions 
 
The TWCCSN2 values for a range of metabolite standards, determined in triplicate using 
standardised settings, measured on two separate instruments (located on different sites) were 
found to be very similar. For DI-IM-MS it was possible to obtain TWCCSN2 values that were 
well within 1% of each other on two different sites and within 1-2% of two external reference 
sources. Application of U(H)PLC separation prior to IM-MS, gave results for 292 (97.0%) 
metabolites that were within ±2% of those measured with DI-IM-MS, with some 270 (89.7%). 
within ±1%. Analysis of rat urine samples by U(H)PLC-IM-MS enabled 65 compounds to be 
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identified using the combination retention time, TWCCSN2 and MS data. This demonstrates the 
potential utility of adding IMS with CCS values to metabolite identification studies. 
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Figure Captions 
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Figure 1. Intra and inter (internal and external Paglia et al. [24]) DI-IM-MS TWCCSN2 
measurement precision. 
 
Figure 2. CCS and MS/MS library coverage (CID fragmentation data/results not shown 
(available for download at http://nonlinear.com/progenesis/qi/v2.2/download/ccs-libraries/ 
and https://marketplace.waters.com/apps/177290/metabolic-profiling-ccs-library#!overview). 
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Figure 3. TWCCSN2 machine-learning prediction (blue) and MetCCS [20] DTCCSN2 based 
prediction (green) values vs. observed TWCCSN2 data. 
 
 
 
Figure 4. Detection frequency as a function of m/z (top) and relative (%) chemical class 
annotation of the library compounds (m/z 150 - 800) (bottom). Blue = detected; red = not 
detected. 
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Figure 5. Class centric m/z vs. CCS relationship based on MeSH (Medical Subject Headings) 
classification. 
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Figure 6. RAMMP LC-IM-MS BPI chromatograms (left), LC-IM-MS-derived vs. DI-IM-MS 
TWCCSN2 values (top right; the biological replication rate is represented by size and the 
sample by colour, blue = control, red = drug dosed) and unsupervised PCA on the 
abundances of the detected metabolites in control and MTX dosed rat urine. The numerical 
TWCCSN2 values, together with the retention times are listed in Table 3 and supplementary 
Table S6, respectively. 
 
 
